173 related articles for article (PubMed ID: 31047751)
1. Design, synthesis and biological evaluation of novel antitumor spirodihydrothiopyran-oxindole derivatives.
Liu W; Chen S; Zhang F; He S; Wang S; Sheng C
Bioorg Med Chem Lett; 2019 Jul; 29(13):1636-1642. PubMed ID: 31047751
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of spiro-tetrahydrothiopyran-oxindoles by Michael-aldol cascade reactions: discovery of potential P53-MDM2 inhibitors with good antitumor activity.
Wang S; Chen S; Guo Z; He S; Zhang F; Liu X; Chen W; Zhang S; Sheng C
Org Biomol Chem; 2018 Jan; 16(4):625-634. PubMed ID: 29302672
[TBL] [Abstract][Full Text] [Related]
3. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
Ji C; Wang S; Chen S; He S; Jiang Y; Miao Z; Li J; Sheng C
Bioorg Med Chem; 2017 Oct; 25(20):5268-5277. PubMed ID: 28797774
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Antitumor Activity of Novel Dispiro[oxindole-cyclohexanone]- pyrrolidines.
Gouda M; Bawazeer M; Hegazy L; Azab M; Elagawany M; Rateb M; Yaseen M; Elgendy B
Curr Pharm Des; 2022; 28(3):198-207. PubMed ID: 34176458
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
Liu SJ; Zhao Q; Peng C; Mao Q; Wu F; Zhang FH; Feng QS; He G; Han B
Eur J Med Chem; 2021 May; 217():113359. PubMed ID: 33725632
[TBL] [Abstract][Full Text] [Related]
8. Studies on the Enantioselective Synthesis of
Yayik N; Pérez M; Molins E; Bosch J; Amat M
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467493
[TBL] [Abstract][Full Text] [Related]
9. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
Islam MS; Ghawas HM; El-Senduny FF; Al-Majid AM; Elshaier YAMM; Badria FA; Barakat A
Bioorg Chem; 2019 Feb; 82():423-430. PubMed ID: 30508794
[TBL] [Abstract][Full Text] [Related]
11. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
[TBL] [Abstract][Full Text] [Related]
12. Organocatalytic Asymmetric Synthesis of Spiro-oxindole Piperidine Derivatives That Reduce Cancer Cell Proliferation by Inhibiting MDM2-p53 Interaction.
Yang MC; Peng C; Huang H; Yang L; He XH; Huang W; Cui HL; He G; Han B
Org Lett; 2017 Dec; 19(24):6752-6755. PubMed ID: 29210587
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p53-Murine Double Minute 2 (MDM2) Interactions with 3,3'-Spirocyclopentene Oxindole Derivatives.
Gicquel M; Gomez C; Garcia Alvarez MC; Pamlard O; Guérineau V; Jacquet E; Bignon J; Voituriez A; Marinetti A
J Med Chem; 2018 Oct; 61(20):9386-9392. PubMed ID: 30221935
[TBL] [Abstract][Full Text] [Related]
14. Stereocontrolled [3+2] Cycloaddition of Donor-Acceptor Cyclopropanes to Iminooxindoles: Access to Spiro[oxindole-3,2'-pyrrolidines].
Akaev AA; Bezzubov SI; Desyatkin VG; Vorobyeva NS; Majouga AG; Melnikov MY; Budynina EM
J Org Chem; 2019 Mar; 84(6):3340-3356. PubMed ID: 30735387
[TBL] [Abstract][Full Text] [Related]
15. Fe
Maddela S; Makula A; Galigniana MD; Parambi DGT; Federicci F; Mazaira G; Hendawy OM; Dev S; Mathew GE; Mathew B
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800174. PubMed ID: 30485473
[TBL] [Abstract][Full Text] [Related]
16. Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.
Rodriguez KX; Howe EN; Bacher EP; Burnette M; Meloche JL; Meisel J; Schnepp P; Tan X; Chang M; Zartman J; Zhang S; Ashfeld BL
ChemMedChem; 2019 Sep; 14(18):1653-1661. PubMed ID: 31140738
[TBL] [Abstract][Full Text] [Related]
17. An overview of spirooxindole as a promising scaffold for novel drug discovery.
Zhou LM; Qu RY; Yang GF
Expert Opin Drug Discov; 2020 May; 15(5):603-625. PubMed ID: 32106717
[No Abstract] [Full Text] [Related]
18. A water mediated multicomponent reaction for the synthesis of novel spirooxindole derivatives and their antifungal activity.
Zhang M; Shi L; Chen L; Liu Z; Zhao T; Zhu C; Yang L
Org Biomol Chem; 2024 May; 22(17):3459-3467. PubMed ID: 38597668
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new LXRβ agonists as glioblastoma inhibitors.
Chen H; Chen Z; Zhang Z; Li Y; Zhang S; Jiang F; Wei J; Ding P; Zhou H; Gu Q; Xu J
Eur J Med Chem; 2020 May; 194():112240. PubMed ID: 32248003
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 3,3'-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands.
Elderwish S; Audebrand A; Nebigil CG; Désaubry L
Eur J Med Chem; 2020 Jan; 186():111859. PubMed ID: 31735574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
